News | September 24, 2012

Top 10 Changes to U.S. FDA Medical Device Registrations and Listings

Registrar Corp reports on the top 10 changes the new U.S. Food and Drug Administration Safety and Innovation Act (FDASIA) imposes on Medical Device Registrations and Listings.

September 24, 2012—The new U.S. Food and Drug Administration Safety and Innovation Act (FDASIA) imposes many Medical Device Establishment Registration and Listings requirements, effective Oct. 1, 2012. To assist the medical device industry, Registrar Corp has provided the following list of top 10 things that medical device professionals need to know regarding FDASIA:

  1. All proprietary names under which a medical device is marketed must be reported, at a minimum, when a medical device is first listed and during the annual update of registration and listing information.
  2. Combination products (i.e. products comprising a medical device and a biological product or a drug) must be identified as a combination product and the type of combination product.
  3. All contract manufacturers and sterilizers of finished medical devices must register and list regardless of whether they put the medical device into commercial distribution or return the medical device to the manufacturer or specification developer.
  4. Initial importers must identify the manufacturers of the medical devices they are importing.
  5. Foreign establishments that are exporting medical devices or offering medical devices for export to the United States must identify all known U.S. importers of their devices.
  6. A device must be listed by the manufacturer, specification developer, single-use medical device reprocessor, remanufacturer or repacker /relabeler before a foreign exporter, contract manufacturer or contract sterilizer can list it.
  7. Establishments that only handle complaints and previously registered as manufacturers or specification developers should change their establishment type to “Complaint File Establishment.”
  8. Establishments located in foreign trade zones must now register and list, as well as identify themselves as being located in a foreign trade zone.
  9. All establishments that are required to register must now pay the annual registration user fee as required by FDASIA.
  10. To have your medical device registration, renewal and listing submitted to FDA by a Regulatory Specialist, simply contact Registrar Corp at +1-757-224-0177. Registrar Corp’s regulatory specialists are available to assist you as the new requirements take effect on Oct. 1, 2012.

 

For more information: www.registrarcorp.com/livehelp

Related Content

Societies Issue New Performance and Quality Measures for Treating Patients with Heart Attack
News | Cath Lab| October 17, 2017
The American College of Cardiology and the American Heart Association recently released updated clinical performance...
First Patient Enrolled in U.S. Arm of ALIVE Pivotal Heart Failure Trial
News | Heart Failure| October 17, 2017
October 17, 2017 — BioVentrix Inc. recently announced enrollment of the first patient in the U.S.
Dee Dee Wang runs Henry Ford Hospital's 3D printing lab for its complex structural heart cardiology program.

Dee Dee Wang, M.D., runs Henry Ford Hospital's 3-D printing lab that supports its complex structural heart program.

Feature | 3-D Printing| October 13, 2017 | Dave Fornell
Three-dimensional (3-D) printed anatomic models created from a patient’s computed tomography (CT), magnetic resonance...
Videos | Chronic Total Occlusion (CTO)| October 09, 2017
Bill Lombardi, M.D., director of complex coronary artery interventions at the University of Washington, discusses the
Medis Releases QAngio CT v3.1
Technology | Computed Tomography (CT)| October 09, 2017
Medis has released a new version of its QAngio CT (computed tomography), which can now be launched from the Medis Suite...
BTG Acquires Roxwood Medical
News | Business| October 05, 2017
BTG plc announced it has acquired Roxwood Medical, provider of advanced cardiovascular specialty catheters used in the...
TVA Medical Receives CE Mark for Next-Generation EverlinQ 4 EndoAVF System
News | Vascular Access| October 04, 2017
TVA Medical Inc. announced that its everlinQ 4 endoAVF System has received CE Mark in the European Union. The...
Reflow Medical's Wingman Crossing Catheter Receives FDA Clearance for Coronary Indication
News | Catheters| October 02, 2017
October 2, 2017 — Reflow Medical Inc. announced that the company has received 510(k) clearance from the U.S.
TherOx Gains FDA PMA Approval for SSO2 Therapy System
Technology | Cath Lab| September 29, 2017
September 29, 2017 — TherOx Inc. announced that the U.S.
Avinger Receives CE Mark for In-Stent Restenosis Indication With Pantheris Image-Guided Atherectomy
Technology | Atherectomy Devices| September 29, 2017
Avinger Inc. recently announced Conformité Européenne (CE) Marking approval for treating in-stent restenosis with the...
Overlay Init